Collagen-alpha-1(XXVIII)-chain Degradome Foundation Atlas

Unlike the major structural fibrillar collagens, collagen XXVIII is characterized by a distinctive domain organization and is associated with specific extracellular matrix environments.</p><p dir="ltr">COL28A1 expression has been particularly associated with peripheral nerves and other tissues, where collagen XXVIII may contribute to the organization and maintenance of specialized extracellular matrix structures. Its association with basement membrane and connective-tissue environments makes its turnover potentially relevant to tissue integrity, extracellular matrix remodeling, and nerve-associated biology.</p><p dir="ltr">Proteolytic processing of collagen XXVIII may generate peptide fragments that are not represented by measurements of the intact protein alone.

Mapping this theoretical fragment landscape therefore provides a foundation for investigating COL28A1-derived peptides as molecular indicators of extracellular matrix turnover, tissue remodeling, and disease-associated proteolysis.</p><h3 dir="ltr">Key Features of the Proteomics Dataset</h3><p dir="ltr">The <b>Collagen Alpha-1(XXVIII) Degradome Foundation Atlas</b> provides a systematic computational representation of the theoretical peptide space associated with the protein, including:</p><ul><li>Predicted enzymatic and chemical cleavage sites across the collagen XXVIII sequence</li><li>Potential contiguous peptide fragments generated through proteolytic cleavage</li><li>Fragment-level physicochemical and biochemical characteristics</li><li>Sequence-derived properties relevant to peptide detectability and characterization</li></ul><p dir="ltr"><b>Mass Spectrometry and Peptide Metrics:</b></p><ul><li>Molecular weight</li><li>Mass-to-charge ratio (m/z)</li><li>Net charge</li><li>Isoelectric point (pI)</li></ul><p dir="ltr"><b>Biochemical and Biophysical Features:</b></p><ul><li>Hydrophobicity</li><li>Boman index</li><li>Instability index</li><li>Aliphatic index</li></ul><p dir="ltr">Together, these calculated parameters provide a feature-rich computational reference for evaluating collagen XXVIII-derived peptides and prioritizing candidates for proteomic and mass-spectrometric investigation.</p><h3 dir="ltr">Applications in Biomarker Discovery and Biomedical Research</h3><p dir="ltr">The dataset can support a range of research applications, including:</p><ul><li><b>Targeted Proteomics:</b> Identification and prioritization of candidate COL28A1-derived peptides for targeted mass-spectrometry assays.</li><li><b>Biomarker Discovery:</b> Exploration of collagen XXVIII-derived peptide signatures associated with extracellular matrix turnover and tissue remodeling.</li><li><b>Discovery Proteomics:</b> Generation of candidate peptide lists for untargeted and discovery-based proteomic studies.</li><li><b>Degradomics:</b> Investigation of proteolytic processing and collagen XXVIII turnover through a protein-specific degradome framework.</li><li><b>Clinical Proteomics:</b> Supporting the identification of peptide signatures associated with tissue-specific extracellular matrix changes.</li><li><b>Extracellular Matrix Research:</b> Characterization of potential collagen XXVIII fragments generated during matrix organization and remodeling.</li><li><b>Neural and Peripheral Nerve Biology:</b> Supporting investigations into COL28A1-associated extracellular matrix structures in peripheral nerve tissues.</li><li><b>Connective Tissue Research:</b> Providing a computational resource for studying collagen XXVIII in specialized connective-tissue environments.</li><li><b>Computational Biology:</b> Enabling sequence-based peptide analysis, degradome profiling, and comparative extracellular matrix studies.</li><li><b>Assay Development:</b> Supporting the selection and characterization of candidate peptides for future experimental validation.</li></ul><h3 dir="ltr">Data Inclusion and Reproducibility</h3><p dir="ltr">Version 1 focuses on the <b>wild-type human collagen alpha-1(XXVIII) chain</b> and provides a systematic theoretical representation of its potential degradome, including contiguous peptide fragments and their calculated physicochemical properties.</p><p dir="ltr">The dataset represents a <b>theoretical fragment space rather than a catalogue of experimentally confirmed peptides</b>.

The presence of a predicted fragment does not establish that the peptide is generated <i>in vivo</i>, remains stable in biological samples, or is detectable by a particular mass-spectrometric platform. Experimental proteomics, degradomics, and mass-spectrometry studies are therefore required to determine which predicted fragments are actually produced and detected under specific biological conditions.</p><p dir="ltr">Future releases of the Collagen Alpha-1(XXVIII) Degradome Foundation Atlas may incorporate disease-associated sequence variants, post-translational and extracellular matrix modifications, experimentally validated cleavage products, and complementary experimental proteomics data.

These extensions will progressively bridge the theoretical peptide landscape with experimentally informed models of collagen XXVIII turnover and extracellular matrix biology.</p><p dir="ltr">This keeps the atlas consistent with your previous collagen entries while giving <b>COL28A1</b> a more specific emphasis on <b>peripheral nerve biology, specialized extracellular matrix environments, and tissue remodeling</b>.</p>